Barclays’s Kura Oncology KURA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$2.33M Buy
403,241
+209,267
+108% +$1.21M ﹤0.01% 2126
2025
Q1
$1.28M Sell
193,974
-7,890
-4% -$52.1K ﹤0.01% 2311
2024
Q4
$1.76M Buy
201,864
+36,380
+22% +$317K ﹤0.01% 2282
2024
Q3
$3.23M Buy
165,484
+84,563
+105% +$1.65M ﹤0.01% 1836
2024
Q2
$1.67M Sell
80,921
-22,991
-22% -$474K ﹤0.01% 1820
2024
Q1
$2.22M Sell
103,912
-103,360
-50% -$2.21M ﹤0.01% 1867
2023
Q4
$2.98M Buy
207,272
+52,027
+34% +$748K ﹤0.01% 1871
2023
Q3
$1.42M Buy
155,245
+32,978
+27% +$301K ﹤0.01% 1874
2023
Q2
$1.29M Sell
122,267
-104,848
-46% -$1.11M ﹤0.01% 1996
2023
Q1
$2.78M Buy
227,115
+41,066
+22% +$502K ﹤0.01% 1429
2022
Q4
$2.31M Sell
186,049
-44,493
-19% -$552K ﹤0.01% 1562
2022
Q3
$3.15M Buy
230,542
+128,990
+127% +$1.76M ﹤0.01% 1360
2022
Q2
$1.86M Buy
101,552
+39,063
+63% +$715K ﹤0.01% 1631
2022
Q1
$1M Sell
62,489
-63,157
-50% -$1.01M ﹤0.01% 2302
2021
Q4
$1.76M Buy
125,646
+42,711
+51% +$598K ﹤0.01% 1879
2021
Q3
$1.55M Buy
82,935
+8,189
+11% +$153K ﹤0.01% 2013
2021
Q2
$1.56M Sell
74,746
-61,456
-45% -$1.28M ﹤0.01% 1866
2021
Q1
$3.85M Buy
136,202
+114,698
+533% +$3.24M ﹤0.01% 1384
2020
Q4
$702K Sell
21,504
-98,642
-82% -$3.22M ﹤0.01% 2159
2020
Q3
$3.68M Buy
120,146
+34,868
+41% +$1.07M ﹤0.01% 1132
2020
Q2
$1.39M Buy
85,278
+49,130
+136% +$801K ﹤0.01% 1710
2020
Q1
$360K Buy
36,148
+923
+3% +$9.19K ﹤0.01% 2275
2019
Q4
$484K Buy
35,225
+18,176
+107% +$250K ﹤0.01% 2710
2019
Q3
$259K Sell
17,049
-4,630
-21% -$70.3K ﹤0.01% 2939
2019
Q2
$427K Buy
21,679
+13,683
+171% +$270K ﹤0.01% 2805
2019
Q1
$133K Buy
+7,996
New +$133K ﹤0.01% 3206
2018
Q4
Sell
-12,965
Closed -$228K 4232
2018
Q3
$228K Buy
12,965
+7,285
+128% +$128K ﹤0.01% 3003
2018
Q2
$103K Sell
5,680
-3,297
-37% -$59.8K ﹤0.01% 3054
2018
Q1
$168K Buy
8,977
+3,600
+67% +$67.4K ﹤0.01% 2924
2017
Q4
$82K Buy
5,377
+4,928
+1,098% +$75.2K ﹤0.01% 3102
2017
Q3
$7K Buy
449
+438
+3,982% +$6.83K ﹤0.01% 3549
2017
Q2
$0 Sell
11
-6,789
-100% ﹤0.01% 3971
2017
Q1
$60K Buy
+6,800
New +$60K ﹤0.01% 3038